Literature DB >> 1413843

Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis.

H J Bonjer1, H A Bruining, J C Birkenhager, R H Nishiyama, M A Jones, C B Bagwell.   

Abstract

Two-hundred seventy-four patients with primary hyperparathyroidism had selective removal of enlarged parathyroid glands. Biopsies were taken from all parathyroid glands. Normal-size glands were not resected irrespective of their histological appearance. After a mean follow-up of 13.5 years the rates of persistent and recurrent hyperparathyroidism were, respectively, 3.6% and 0.7%. Transient and permanent hypoparathyroidism occurred in 24% and 2.5% of the patients. The microscopic appearance of enlarged glands and of biopsies taken from normal-size glands were reviewed by two pathologists. Normal parathyroid glands were distinguished from abnormal glands fairly accurately (sensitivity 93%, specificity 80%). Microscopic classification of abnormal parathyroid glands as adenomas or hyperplastic glands correlated poorly with the gross classification as single or multigland disease. Flow cytometric DNA analysis of paraffin embedded parathyroid tissue showed significant differences for DNA index, % S-phase and % G2M (p less than 0.001). Differentiating single from multigland disease by means of DNA analysis was not possible. In conclusion, removal of only enlarged parathyroid glands results in acceptable rates of persistent and recurrent hyperparathyroidism. Biopsies should only be taken sparingly to prevent transient and permanent hypoparathyroidism. Microscopic examination and flow cytometric DNA analysis can differentiate normal from abnormal parathyroid glands but are unable to differentiate abnormal glands into single or multigland disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413843     DOI: 10.1007/bf02067373

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Hyperparathyroidism today.

Authors:  E Paloyan; D Paloyan; J R Pickleman
Journal:  Surg Clin North Am       Date:  1973-02       Impact factor: 2.741

2.  Trends in the current management of primary hyperparathyroidism.

Authors:  R C Haff; R G Armstrong
Journal:  Surgery       Date:  1974-05       Impact factor: 3.982

3.  DNA histogram of parathyroid tissue in determining extent of parathyroidectomy.

Authors:  I B Rosen; C E Musclow
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

4.  Relation of postoperative hypocalcemia to operative techniques: deleterious effect of excessive use of parathyroid biopsy.

Authors:  E L Kaplan; S Bartlett; J Sugimoto; A Fredland
Journal:  Surgery       Date:  1982-11       Impact factor: 3.982

5.  Flow cytometric DNA analysis of normal and pathologic parathyroid glands.

Authors:  S Harlow; S I Roth; K Bauer; R B Marshall
Journal:  Mod Pathol       Date:  1991-05       Impact factor: 7.842

6.  Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications.

Authors:  L S Bowlby; L E DeBault; S R Abraham
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

7.  The parathyroid adenoma. A histopathologic definition with a study of 172 cases of primary hyperparathyroidism.

Authors:  L Ghandur-Mnaymneh; N Kimura
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

8.  Fat staining in parathyroid disease--diagnostic value and impact on surgical strategy: clinicopathologic analysis of 191 cases.

Authors:  A G Bondeson; L Bondeson; O Ljungberg; S Tibblin
Journal:  Hum Pathol       Date:  1985-12       Impact factor: 3.466

9.  The role of the pathologist in the surgical treatment of hyperparathyroidism.

Authors:  A W Saxe; R Baier; H Tesluk; W Toreson
Journal:  Surg Gynecol Obstet       Date:  1985-08

10.  The role of routine biopsy of all parathyroid glands in primary hyperparathyroidism.

Authors:  W C McGarity; P P McKeown; C W Sewell
Journal:  Am Surg       Date:  1985-01       Impact factor: 0.688

View more
  9 in total

1.  Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease.

Authors:  Thomas Clerici; Michael Brandle; Jochen Lange; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

2.  Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration?

Authors:  P C Smit; I H Borel Rinkes; A van Dalen; T J van Vroonhoven
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Surgical treatment of hyperparathyroidism using the quick parathyroid assay.

Authors:  Stacy L Stratmann; Joseph A Kuhn; John T Preskitt; John C O'Brien; Jeffrey S Stephens; Todd M McCarty
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

4.  National survey on the management of primary hyperparathyroidism by Swiss endocrinologists.

Authors:  T Clerici; R Warschkow; F Triponez; M Brändle
Journal:  Langenbecks Arch Surg       Date:  2007-02-09       Impact factor: 3.445

5.  25-hydroxy vitamin D deficiency causes parathyroid incidentalomas.

Authors:  James Kirkby-Bott; Ziad El-Khatib; Benoit Soudan; Robert Caiazzo; Laurent Arnalsteen; Bruno Carnaille
Journal:  Langenbecks Arch Surg       Date:  2010-08-19       Impact factor: 3.445

6.  A new approach to parathyroidectomy.

Authors:  G L Irvin; D L Prudhomme; G T Deriso; G Sfakianakis; S K Chandarlapaty
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

7.  Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy.

Authors:  S Tezelman; W Shen; J K Shaver; A E Siperstein; Q Y Duh; H Klein; O H Clark
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

8.  Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.

Authors:  Naris Nilubol; Allison B Weisbrod; Lee S Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

9.  The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism.

Authors:  Mechteld C de Jong; K Jamal; S Morley; T Beale; T Chung; S Jawad; S Hurel; H Simpson; U Srirangalingam; S E Baldeweg; V Rozalén García; S Otero; M Shawky; T E Abdel-Aziz; T R Kurzawinski
Journal:  Hormones (Athens)       Date:  2020-05-13       Impact factor: 2.885

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.